Balaji Amines Limited has informed the Exchange about General Updates: consent received to operate the manufacture of ISOPROPYLAMINE (MIPA/ DIPA).
BALAMINES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaji Amines Limited has received regulatory consent to operate the manufacture of Isopropylamine (MIPA/DIPA), a new product in its chemicals portfolio. The company will begin trial runs shortly, with commercial production expected to commence soon thereafter. This represents an expansion of the company's product offerings in the amines segment. The disclosure has been made under SEBI Listing Regulations to keep the stock exchanges informed.
Positive for shareholders as this adds a new revenue stream and diversifies the company's product mix. Commercial production commencement in the near term could boost future earnings, though the exact capacity and financial impact are not disclosed.